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Raynaud PhenomenonDecreasing the temperature to 30 °C is accompanied by signiﬁcant enhancement ofα2C-AR plasmamembrane
levels in several cell lines with ﬁbroblast phenotype, as demonstrated by radioligand binding in intact cells. No
changes were observed on the effects of low-temperature after blocking receptor internalization in α2C-AR
transfected HEK293T cells. In contrast, two pharmacological chaperones, dimethyl sulfoxide and glycerol,
increased the cell surface receptor levels at 37 °C, but not at 30 °C. Further, at 37 °Cα2C-AR is co-localized with
endoplasmic reticulum markers, but not with the lysosomal markers. Treatment with three distinct HSP90
inhibitors, radicicol, macbecin and 17-DMAG signiﬁcantly enhanced α2C-AR cell surface levels at 37 °C, but
these inhibitors had no effect at 30 °C. Similar results were obtained after decreasing the HSP90 cellular levels
using speciﬁc siRNA. Co-immunoprecipitation experiments demonstrated that α2C-AR interacts with HSP90
and this interaction is decreased at 30 °C. The contractile response to endogenous α2C-AR stimulation in rat
tail artery was also enhanced at reduced temperature. Similar to HEK293T cells, HSP90 inhibition increased
the α2C-AR contractile effects only at 37 °C. Moreover, exposure to low-temperature of vascular smooth
muscle cells from rat tail artery decreased the cellular levels of HSP90, but did not change HSP70 levels. These
data demonstrate that exposure to low-temperature augments theα2C-AR transport to the plasmamembrane
by releasing the inhibitory activity of HSP90 on the receptor trafﬁc, ﬁndings whichmay have clinical relevance
for the diagnostic and treatment of Raynaud Phenomenon.+1 504 568 2361.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
The effects of circulating catecholamines are mediated by speciﬁc
plasma membrane proteins, named adrenergic receptors. Adrenergic
receptors aremembers of the G protein coupled receptors superfamily
(GPCR) and are divided into β, α1 and α2-AR [1]. Three distinct genes
have been identiﬁed that encode for separate subtypes of α2-AR [2,3].
Lacking speciﬁc ligands, the progress in understanding α2-AR
pathophysiology was based on genetic models individually targeting
each subtype [4,5]. These studies demonstrated distinct tissue
distribution and functional roles for each α2-AR subtype. Speciﬁcally,
α2C-AR is expressed in brain, atria, kidney, and hepatic cells, and in
vascular smooth muscle cells (VSMC) from the peripheral vasculature
[2–5]. Like other α2-AR subtypes, the cellular effects of α2C-AR are
mediated by coupling to Gαi leading to inhibition of adenylate cyclase,
inhibition of voltage Ca2+ channels, stimulation of phospholipase C,
A2 and D and activation of MAP kinases [2–5]. A functional coupling to
Gαs has also been reported for α2-AR, but it is apparent only at high
agonist concentration or after inhibition of Gαi and its physiological
signiﬁcance remains unknown [6,7]. In the heterologous systems,
α2C-AR is poorly transported to the plasma membrane [8,9]. Incontrast, in the neuroendocrine cell lines the receptor is efﬁciently
targeted to the plasma membrane, suggesting a cell speciﬁc α2C-AR
intracellular trafﬁcking [8,9]. Overall, α2C-AR remains the least
characterized α2-AR subtype, and the mechanisms regulating the
receptor intracellular trafﬁcking are not fully understood.
However, a role ofα2C-AR in the pathology of Raynaud Phenomenon
has been suggested. This disease is characterized by enhanced
vasoconstriction in response to cold, emotional stress or exposure to
vibrations [10,11]. The involvement of an unknownα2-AR subtype was
suggested by early publications of Flavahan and Freedman groups,
based on the observation that the α2-AR stimulation modulates the
vasoconstriction at reduced temperature, whereas α1-AR has no effect
[12,13]. Subsequently, elegant work from Flavahan's group demon-
strated that the vascular tone at low-temperature is speciﬁcally
modulated by the α2C-AR subtype, which is silent at 37 °C but it is
functional at lower temperatures [14,15].
During the last decade, signiﬁcant progress was made in
understanding the mechanisms controlling the intracellular protein
trafﬁc from the folding site represented by the endoplasmic reticulum
to the functional destination [16,17]. It has been found that many
newly synthesized proteins are transported along the biosynthetic
pathway in an inefﬁcient manner [17–19]. For example, within the
GPCR class, only 50% of the newly synthesized δ-opioid receptors are
transported to the plasma membrane [20]. The fate of the newly
synthesized GPCR results from the interactions with several
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These molecular chaperones are heterogeneous, with different subcellu-
lar localization (cytosol, Golgi, endoplasmic reticulum) andhave different
outcomes on the chaperoned protein, like improving the folding status
and favoring the transport, or determining intracellular retention and
proteasomal degradation. Thus, it is not surprising that interfering with
the activity or expression of different molecular chaperones has been
found to change the rate of intracellular transport for several proteins.
Likewise, downregulation of the cellular levels of AHSA1, a HSP90 co-
chaperone, enhanced the cell surface of CFTR Δ508 mutant [21]. In
contrast, inhibition of HSP90 activity decreased the maturation rate of
insulin receptor and nicotinic receptors [22,23]. Currently few speciﬁc
pharmacological agents are available to modulate the activity of
molecular chaperones. This deﬁcit is partly compensated by several
non-speciﬁc compounds, named pharmacological chaperones, which
were shown to stabilize the misfolded proteins and allow their
progression in the biosynthetic pathway [17,24,25]. The non-speciﬁc
pharmacological chaperones are including osmolytes (dimethyl sulfoxide
and glycerol), inhibitors of sarco(endoplasmic) reticulum Ca2+ ATP-ase
and factorsmodifying the heat shock response. Interestingly, exposure to
low-temperature has also been suggested to function in the sameway as
non-speciﬁc pharmacological chaperones, improving the subcellular
transport of CFTR Δ508 mutant and potassium channels human
ether-a-go-go-related gene channels [26–28].
Understanding the mechanisms regulating the intracellular
trafﬁcking of speciﬁc proteins can provide new therapeutic
approaches to several diseases caused by accumulation of misfolded
proteins. Therefore, in the present work we studied the subcellular
localization of α2C-AR at 37 °C and at low-temperature and we
investigated the mechanisms underlying the particular receptor
intracellular trafﬁcking.
2. Materials and methods
2.1. Plasmids
Humanα2C-AR wild-type receptor in pcDNA3.1+ vector was a gift
from Dr. D. Bylund (University of Nebraska Medical Center). Human
HA-tagged-α2C-AR was a gift from Drs. C. Hurt and T. Angelotti
(Stanford University Medical School). Human α2C-322–325del-AR and
not-tagged and 3×HA tagged α2B-AR in pcDNA 3.1+ vector were
bought from Missouri S&T cDNA Resource Center. HSP90AB and
GRP94 in pCMV5 vector were from Origene. DsRed-Rab7 was from
Addgene (plasmid 12661). Human α2C-AR and α2B-AR tagged with
GFP at their C-termini were generated by PCR after the stop codonwas
mutated, and the sequences restricted with HindIII/SalI in frame with
GFP were ligated into the pEGFP-N1 vector (Clonetech).
2.2. Antibodies and chemicals
The sources of the antibodies used in the present study were as
follows: anti-GFP, anti-hemagglutinin (anti-HA), Na+/K+ ATP-ase
and β-actin were from Santa Cruz Biotechnology; anti-HSP70 and
anti-GM130 were from BD Biosciences and anti-HSP90was from Enzo
Life Sciences; rabbit polyclonal α2C-AR antibody corresponding to the
aminoacids 309–324 from the receptor third intracellular loop was
from Abcam; ﬂuorescently labeled secondary antibodies (Alexa Fluor
594-labeled anti-mouse and anti-rabbit), and 4,6-diamidino-2-
phenylindole were obtained from Invitrogen. Macbecin and 17-
DMAG were from Enzo Life Sciences and radicicol was from Sigma
Aldrich. Lactacystin and MG132 were from Tocris.
2.3. Cell culture and transient transfection
HEK293T cells were cultured in Dulbecco's modiﬁed Eagle's
medium (DMEM) with 10% fetal bovine serum, 100 U/ml penicillin,and 100 μg/ml streptomycin. Transient transfection of the HEK293T
cells was carried out using LipofectAMINE 2000 reagent (Invitrogen),
following the manufacturer instructions. In brief, HEK293T cells were
cultured on 10 cm2 dishes and transfected at ~80% conﬂuency with
3 μg receptor construct in DMEM with no antibiotics and no FBS. Six
hours later the cells were trypsinized and plated at a density of 106
cells/well in 6-well plates for western blot experiments, or 4×105
cells/well in 12-well plates for radioligand binding experiments and
cAMP determination. For co-transfections experiments, the cells
were cultured on 6-well plates and transfected with 0.5 μg α2C-AR
and 2.5 μg pcDNA3.1 or GRP94 per well. After six hours the cells
were trypsinized and plated on 12-well plates as above. For siRNA
studies, HEK293T cells in 10 cm2 dishes were ﬁrst transfected with
α2C-AR (3 μg/plate) and after 6 h were trypsinized and plated on
12-well plates together with siRNA complexes (3 nM/well) in
Transfection Agent 1 following themanufacturer instructions (Applied
Biosciences).
2.4. Ligand binding in intact cells
The cells in 12-well plates were serum starved for 24 h to prevent
differential proliferation at different temperatures and we found no
differences in cell number in these conditions. Eighteen hours before the
experimental procedure, half of the plates were transferred to a similar
incubator at 30 °C, whereas the other were incubated at 37 °C and served
as control. Two days after transfection the medium was aspired and the
cells were incubated in DMEM containing 20 nM [3H]-RX821002 for four
hours at 4 °C. The binding was terminated by aspiration of the
radioactivity and the cellswerewashed three timeswithDMEM,digested
with 1 M NaOH, and the bound radioactivity was determined in a
β-scintillation counter. The non-speciﬁc binding determined in presence
of non-radioactive rauwolscine (10 μM) represented less than 10% of
the total radioactivity and it was subtracted from the presented results.
In preliminary experiments we found that performing the binding
procedure at low-temperature prevents [3H]-RX821002 internalization.
This was tested by washing the cells three times with 50 mM glycine
(pH=3) to remove plasma membrane bound radioactivity. Subse-
quently the cells were trypsinized and fractionated using Qproteome
cell compartment kit (Qiagen) and the radioactivity was determined in
each fraction. Most of the radioactivity (89±3%, n=3) was present in
the initial acidic washouts, and the remaining was present in the
membrane fraction (7±2%) and in the cytosolic fraction (5±3%,
n=3).
2.5. Flow cytometry
For measurement of total receptor expression, HEK293T cells were
transiently transfected with 500 ng of GFP-tagged receptors for 48 h.
The cells were collected, washed twice with PBS and resuspended at a
density of 8×106 cells/mL. Total GFP ﬂuorescence was then measured
on a ﬂow cytometer (BD Biosciences FASCalibur) as described
previously [29,30].
2.6. Fluorescence microscopy
For ﬂuorescence microscopic analysis of receptor subcellular
localization, HEK293T cells were grown on coverslips pre-coated
with poly-L-lysine in 6-well plates and transfected with 500 ng of
GFP-tagged receptors. For colocalization of GFP-tagged receptors with
the ER and lysosomal markers, HEK293T cells grown on coverslips
were transfected with 500 ng of GFP-tagged receptors and 300 ng of
pDsRed2-ER or pDsRed2-Rab7. The cells were ﬁxed with 4%
paraformaldehyde–4% sucrose mixture in PBS for 15 min and stained
with 4, 6-diamidino-2-phenylindole for 5 min. For colocalization of
GFP-tagged receptors with the cis-Golgi marker GM130 or with the
plasma membrane marker Na+/K+ ATP-ase, HEK293T cells were
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blocked with 5% normal donkey serum for 1 h. The cells were then
incubated with antibodies against GM130 (BD Biosciences) or Na+/K+
ATP-ase (Santa Cruz) at a dilution of 1:100 for 1 h. After washing with
PBS (3×5 min), the cells were incubated with Alexa Fluor 594-labeled
secondary antibody (1:1000 dilution) for 1 h at room temperature.
The coverslips were mounted, and ﬂuorescence was detected with a
Leica DMRA2 epiﬂuorescent microscope as described previously
[30,31]. Images were deconvolved using SlideBook software and the
nearest neighbor deconvolution algorithm (Intelligent Imaging
Innovations).
2.7. Co-immunoprecipitation
Immuno-precipitation of the receptors was performed in similar
manner as described [29]. In brief, HEK293T cells were cultured on
10 cm2 dishes and transfectedwith 3 μg ofHA-taggedα2C-AR orα2B-AR
for 48 h. The cells were washed twice with PBS and harvested. The cells
were then lysed with 300 μl of lysis buffer containing 50 mM Tris–HCl,
pH 7.4, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS
and Complete Mini protease inhibitor cocktail. After gentle rotation for
1 h, samples were centrifuged for 15 min at 14,000×g and the
supernatant was incubated with 50 μl of protein G Sepharose for 1 h
at 4 °C to remove non-speciﬁc bound proteins. Samples were then
incubated with 5 μg of anti-HA antibodies overnight at 4 °C with gentle
rotation followed by incubationwith 50 μl of protein G sepharose beads
for 5 h. Resin was collected by centrifugation and washed four times
with 500 μl of lysis buffer. Immunoprecipitated receptors were eluted
with 100 μl of 1× SDS-PAGE loading buffer, separated by 10% SDS-PAGE
and visualized by immunoblotting using speciﬁc antibodies.
2.8. Western Blotting
Western blot analysis of protein expression was carried out as
previously described [29–32]. Samples were separated by SDS-PAGE
and transferred onto polyvinylidene diﬂuoridemembranes. The signal
was detected using ECL Plus (PerkinElmer Life Sciences) and a Fuji
Film luminescent image analyzer (LAS-1000 Plus) and quantitated
using the Image Gauge program (Version 3.4).
2.9. Measurement of cAMP production
cAMP concentrations were measured by using cAMP enzymeim-
munoassay system (Cayman Chemical Company) as described
previously [32]. HEK293T cells on 10 cm2 plates were transfected
with 3 μg α2C-AR and six hours later were split into 12-well plates.
The cells were serum starved for 24 h and then incubated at 37 °C
or at 30 °C in absence or presence of macbecin (5×10−6 M) for the
next 18 h. One hour before stimulation the medium was changed to
PBS supplemented with isobutylmethylxanthine (100 μM). Then the
cells were incubated with 10−8 M UK14304 for 5 min, followed by
stimulation with forskolin (10 μM) for 15 min. The reactions wereFig. 1. The effects of low-temperature on the plasma membrane expression of human α2C-A
after 6 h were trypsinized and plated on 12-well plates at ~80% conﬂuence. Twelve hours lat
exposed to 30 °C for the time periods indicated on the x-axis. The α2C-AR cell surface levels w
Methods; mean±SD, n=4–12 for each point B. Time-dependent increase inα2C-AR plasma
in A, exposed for 18 h at the temperatures indicated on the x-axis and the cell surface lev
membrane levels of α2C-AR at 37 °C (black symbols) and at 30 °C (white symbols) determi
concentrations of [3H]-RX821002 and the bound radioactivity was determined by liquid
D. Same as in E, but forα2B-AR transfected HEK293T cells; n=4–12 for each point. E. Total lev
30 °C (white columns) were determined by ﬂow cytometry measuring GFP ﬂuorescence;
independent transfections. F. The plasma membrane levels of α2C-AR wild type (wt) andα2C
in intact HEK293T cells; mean±SD, n=12 in each case from four different transfections
HEK293T cells at 37 °C (black bars) and at 30 °C (white bars); mean±SD, n=4–12 in eachstopped by aspirating the medium and addition of 200 μl of acetic
acid (4%). Twenty ﬁve microliters of cell lysate was then transferred
into microtitre plate and the cAMP levels were determined by ELISA
according to the manufacturer protocol.2.10. Contractile studies
Rat tail arteries were removed from male Wistar rats, and stored
overnight in a cold (4 °C), oxygenated Krebs bicarbonate solution of
the following composition (mmol/L): NaCl 118, KCl 4.7, CaCl2 2.5,
MgSO4 1.2, KH2 PO4 1.2, NaHCO3 25 and glucose 8.3; pH 7.4. Artery
segments were mounted in Mulvany myographs (J.P. Trading) with
separated 6-mL organ baths containing Krebs bicarbonate solution,
aerated with 95% O2 and 5% CO2, and maintained at 37 °C. Tissue
responses were measured as changes in isometric force, using a
Harvard isometric transducer. Following a 30-min stabilization
period, the optimal internal diameter was set to a tension
equivalent to 0.9 times the estimated diameter at 100 mm Hg
effective transmural pressure as described by Mulvany and Halpern
[33]. To determine the maximum contractile response, the tissue
was exposed to 100 mmol/L KCl. The segments were then allowed
to equilibrate in fresh organ bath ﬂuid in the presence of BRL44408
(α2A-AR receptor antagonist), L-NAME (NOS inhibitor), and macbe-
cin for 30 min at 37 °C. Subsequently concentration–response curves
were constructed with the α2-AR receptor agonist UK14304. Then,
the protocol was repeated at 30 °C, after washing and one hour re-
equilibration at this temperature. This washing period was sufﬁcient
to fully restore the response to UK14304 when the experiment was
repeated at 37 °C.2.11. Isolation of vascular smooth muscle cells from rat tail artery
All procedures were reviewed and approved by the health sciences
animal and welfare committee of the LSU Health Sciences Center.
Central tail arteries from male Wistar rats were dissected, immersed
in cold PBS without Ca2+ and Mg2+, and cleaned by the connective
tissue. The arteries were cut in small pieces (~0.5 cm3 each) and
incubated with collagenase (type, 1 mg/ml) elastase (0.5 mg/ml),
trypsin inhibitor (2 mg/ml) and bovine serum albumin (2 mg/ml) for
three hours at 37 °C with gentle rotation. The cells were collected by
centrifugation (200 g for 5 min) and plated at a density of ~106 cells in
10 cm2 dishes containing DMEM supplemented with 10% FBS and
100 U/ml penicillin, and 100 μg/ml streptomycin. The medium was
changed each 2–3 days and the cells were trypsinized near con-
ﬂuency. The vascular smooth muscle phenotype was conﬁrmed by
anti-caldesmon antibodies which demonstrated that over 95% of the
cells were smooth muscle myocytes. All experiments were performed
in the second passage on cells plated on 6-well plates at a density of
~5×105 cells/well. The cells were serum starved for 48 h and then
expose to 30 °C for 18 h in similar manner as described for HEK293T
cells.R. A. The six cell lines indicated were transfected with α2C-AR (3 μg/10 cm2 plate) and
er the mediumwas changed to DMEMwithout FBS and after another 12 h the cells were
ere determined by [3H]-RX821002 binding in intact cells as described in Materials and
membrane levels in transfected HEK293T exposed at 30 °C. The cells were transfected as
els were determined in intact cells; mean±SD, n=4–12 in each case. C. The plasma
ned in intact HEK293T cells. The cells were incubated at 4 °C for 4 h with the indicated
scintillation spectrometry; n=4–12 for each point, from four different transfections.
els ofα2C-AR (left columns) andα2B-AR (right columns) at 37 °C (black columns) and at
data are presented as mean±SD from the values obtained at 37 °C, n=3 from three
322–325del-AR isoform (GAGP) at 37 °C (black bars) and at 30 °C (white bars) determined
. G. The plasma membrane levels of untagged, GFP-tagged and HA-tagged α2C-AR in
case.
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Each experiment was repeated at least in three independent trans-
fections and the data are shown as mean±SD. The statistical differenceswere tested using one-way ANOVA followed by Bonferonni test, pb0.05
being considered signiﬁcantly different. The Kd values forα2C-AR andα2B-
ARat37 °Candat30 °CwerecalculatedusingGraphPadSoftware(version
5.01) and nonlinear regression for best ﬁt to a one-site binding model.
Table 1
Ligand binding properties of α2C-AR and α2B-AR at 37 °C and 30 °C in isolated
membranes and in intact cells.
Receptor Isolated membranes Intact cells
37 °C 30 °C 37 °C 30 °C
α2C-AR 5.72±1.4 nM 6.36±0.98 nM 1.87±0.33 nM 2.08±0.32 nM
The receptor levels in transfected HEK293T cells were determined by [3H]-RX821002
binding in isolatedmembranes or in intact cells as described inMaterials andmethods. The
Kd values in each case were determined by nonlinear regression for best ﬁt to a one-site
binding model.
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3.1. The effects of low-temperature on the α2C-AR plasma membrane
levels
Previously it has been shown that the functional responses to α2C-AR
stimulation are enhanced at low-temperature and that the receptor
accumulates intracellularly at37 °C [8,9,14,15].However, themechanisms
underlying theparticular receptor trafﬁcking remainpoorly characterized.
Toﬁll this gap, in thepresent study theplasmamembraneα2C-AR levels in
transfected cell lines were determined by radioligand binding in intact
cells. As different α2C-AR localization were noted on in ﬁbroblasts and
neuro-endocrine cells [8,9], the effects of low-temperature were
evaluated in a variety of cell lines (Fig. 1A). Exposure to 30 °C signiﬁcantly
enhanced the α2C-AR plasma membrane levels in all cell lines with
ﬁbroblast phenotype in time-dependentmanner (Fig. 1A). In six such cell
lines, a signiﬁcant increase in cell surface receptor levels was observed
after 6 h, but themaximal effectwas observed after 18 hexposure at 30 °C
(Fig. 1A). In contrast, exposure to low-temperature had no effect on the
receptor levels in the neuro-endocrine cell line, PC12 (Fig. 1A). The largest
increase of α2C-AR plasma membrane levels at 30 °C was found in
HEK293T cells (Fig. 1A), and this cell linewas selected to further study the
mechanisms involved in the regulation of receptor trafﬁcking by low-
temperature.
Next, the temperature ranges stimulating the α2C-AR trafﬁcking to
the plasmamembrane were determined. Because long-term exposure
at temperatures lower than 25 °C induces irreversible changes in the
cytoskeletal structures [25,28], the present study was limited to study
the effects of temperatures above 28 °C. The maximal increase in the
cell surface receptor levels was found at 30 °C (Fig. 1B). As exposure to
low-temperatures in the range of 28–32 °C is often used to enhance the
plasmamembrane expressionofmisfoldedproteins [17,25,28], the effects
of low-temperaturewere also assessed on the closestα2C-AR homologue,
α2B-AR. Although these two receptors share more than 80% homology,
exposure to low-temperature had no effect on the α2B-AR plasma
membrane levels, (Fig. 1D). In contrast, signiﬁcant augmentation of the
α2C-AR cell surface levels was found in cells exposed to 30 °C (Fig. 1C).
Similar results were obtained in the puriﬁed isolated plasma membrane
fraction (Supplementary Figure 1). These increases cannot be explained
by changes of the afﬁnity of the ligand for the receptor, because similar Kd
values were calculated at 37 °C and 30 °C by the two different methods
(Table 1). To further eliminate the possibility that the observed
enhancement in the plasma membrane receptor number is the result of
enhanced total receptor levels due to increasedsynthesis ordiminishment
in the protein degradation at low-temperature, the total cellular levels of
α2C-AR and α2B-AR were determined by ﬂow-cytometry. No signiﬁcant
differences in the total numberof receptorswere foundat 37 °Cor at 30 °C
for any α2-AR subtype (Fig. 1E).
An α2C-AR splicing variant missing four amino acids in the
positions 322GAGP325 (α2C322–325del-AR) in the third intracellular
loop has been identiﬁed and it has been proposed to contribute to the
ethnic differences to cardiovascular stress responses [1,34,35]. However,
when transfected in HEK293T cells, bothα2C-AR isoforms showed similar
augmentations in the plasma membrane levels at low-temperature
(Fig. 1F). Formanybiochemical approaches, receptor tagging is a common
method enabling visualization and receptor pull-down and for this study
GFP- and HA-α2C-AR were generated. These tagged receptors displayed
the same temperature-dependent upregulation in the cell surface
receptor levels as parent construct (Fig. 1G).
3.2. Subcellular distribution of α2C-AR at physiological temperature
The receptor number present at the plasma membrane is the result
of the ﬁne equilibrium between receptor internalization and receptor
export. To assess if the effects of low-temperature on the α2C-AR are
causedby inhibitionof receptor internalization,ﬁrst theeffects of typicalα2 agonist, UK14304 were tested on the receptor cell surface levels at
37 °C andat 30 °C. As shown in Fig. 2A, even incubationsup to fourhours
with the agonist did not change the effects of low-temperature on the
upregulation of α2C-AR plasma membrane. To further test the
involvement of receptor internalization, the effects of two well
characterized proteins interfering with GPCR internalization, Rab5 and
Dynamin I, were investigated. Co-transfection with dominant negative
isoforms Rab5N135I and Dynamin I K44A did not change the α2C-AR
plasma membrane levels at 37 °C or at 30 °C (Fig. 2B). In contrast, the
treatment with the non-speciﬁc chemical chaperones, dimethyl
sulfoxide and glycerol signiﬁcantly enhanced the receptor plasma
membrane levels at 37 °C, but they were ineffective at 30 °C (Fig. 2C).
The main mechanism involved in the actions of chemical chaperones is
stabilization of themildlymisfolded proteins allowing their inclusion in
the biosynthetic pathway. Thus, these results indicate that defects in the
receptor export, but not in the receptor internalization are the
explanation for α2C-AR intracellular localization at 37 °C.
To further conﬁrm this hypothesis, deconvolution microscopy was
used to determine GFP-α2C-AR subcellular localization at 37 °C and at
30 °C. As expected from radio-ligand binding experiments, at 37 °C most
of the receptor was found to accumulate intracellularly in the perinuclear
regions, overlappingwith the endoplasmic reticulummarkerpDsRed2-ER
(Fig. 3A). In contrast, at 30 °C, most of the GFP-α2C-ARwas present at the
plasma membrane (Fig. 3B). In agreement with previous reports [8],
occasionally at 37 °C the receptor was found to be co-localized with the
cis-Golgimarker,GM130(Fig. 3C).However, either at37 °Cor at 30 °C, the
receptor did not co-localize with the lysosomal marker, Rab7 (Fig. 3D).
Theseﬁndings indicate again that defects in the receptor export, but not in
the receptor internalization, are responsible for α2C-AR intracellular
accumulation at the physiological temperature.
3.3. The effects of HSP90 inhibition on the α2C-AR intracellular trafﬁc in
HEK293T cells
Recently it has been shown that alterations in the HSP90 activity
may change the intracellular trafﬁcking of different proteins like CFTR,
AchR and the insulin receptor [21–23]. To test if this is the case for
α2C-AR, the effects of three distinct HSP90 inhibitors were tested on
the receptor cell surface levels at 37 °C and at 30 °C. At 37 °C,
macbecin, 17-DMAG and radicicol signiﬁcantly enhanced the number
of α2C-AR plasma membrane binding sites to similar levels as
observed at 30 °C (Fig. 4A). In contrast, these compounds were
ineffective at 30 °C. Macbecin pretreatment did not change the Kd
values of [3H]-RX821002 binding to α2C-AR at 37 °C or at 30 °C
(Supplementary Table 1), indicating that these effects are not due to
changes in the ability of the receptor to bind the ligand. Further,
although HSP90 inhibitors also slightly increase the α2B-AR plasma
membrane levels, this effect is signiﬁcantly smaller than the increase
observed on the α2C-AR (Fig. 4A). The effects were dose-dependent
and similar between the α2C-AR wild-type and α2C322–325del-AR
splicing variant (Fig. 4B). To exclude the possibility that these
inhibitors may modulate receptor trafﬁc independent of HSP90, the
relation between endogenous levels of HSP90 and α2C-AR cell surface
expression was examined. Using HSP90 siRNA in α2C-AR transfected
Fig. 3. The subcellular localization of GFP-taggedα2C-AR at 37 °C (left column) and at 30 °C
(right column). HEK293T were transfected with 1 μg per 10 cm2 plate with GFP-tagged
receptors and processed in the same way as for radio-ligand binding. The individual
organelles were identiﬁed as follows: A. The endoplasmic reticulum was visualized by co-
transfection with the speciﬁc marker pDsRed2-ER. B. The plasma membrane was stained
using Na+/K+ ATP-ase antibody as described in Materials and methods. C. Cis-Golgi was
labeledafter incubationwithGM130antibody.D. The lysosomal compartmentwas visualized
by co-transfection with DsRed2-Rab7. The cells were ﬁxed with 4% paraformaldehyde–4%
sucrose mixture and the distribution of α2C-AR was analyzed by ﬂuorescence microscopy.
Blue: DNA staining by 4,6-diamidino-2-phenylindole (nuclear), green: GFP-α2C-AR, red:
speciﬁc organelle indicated in the ﬁgure, yellow: co-localization of the receptor with the
respective organelle marker. The images are representative from at least six different
coverslips, obtained from three independent transfections.
Fig. 2. The roles of receptor internalization and chemical chaperones in the temperature-
dependentα2C-AR trafﬁcking. A. The cellswereprocessedas above andα2C-AR transfected
HEK293T cells maintained at 37 °C or at 30 °C for 18 h prior determinations were
incubated with UK14304 (10−4 M) for 1 (white bars) and 4 h (hatched bars) at each
temperature and the receptor plasmamembrane levels were determined in intact cells by
[3H]-RX821002 binding. mean±SD, n=6–10 in each case. B. Same as in A, but HEK293T
cells were co-transfected with α2C-AR (0.5 μg) and 3 μg of pcDNA 3.1+ (P, black bars),
Rab5N135I (R5, white bars ) or Dynamin I K44A (D, hatched bars) and the receptor cell
surface levels were determined in similar manner, mean±SD, n=4–8 from 2 different
transfections. C. The effects ofDMSO(2%,white bars) andglycerol (4%hatched bars) on the
α2C-AR plasma membrane levels at 37 °C and at 30 °C; n=8–12 in each case from four
different transfections, *pb0.05.
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obtained (Fig. 4C). This reduction was enough to enhance the plasma
membrane receptor levels at 37 °C to the same levels as found by
using HSP90 inhibitors (Fig. 4D). Again, the diminishment in HSP90
levels had no effect on the receptor cell surface levels at 30 °C, strongly
suggesting that low-temperature stimulate receptor trafﬁc to the cell
surface by interfering with HSP90 activity. Co-immunoprecipitation
experiments demonstrated interactions between α2C-AR and the
cytosolic HSP90 (Fig. 5A). Interestingly, these interactions were
temperature-dependent, as exposure to 30 °C for 18 h reduced the
interactions between the two proteins with about ~80% (Fig. 5B). A
similar inhibition in the interactions between α2C-AR and HSP90 wasfound in the cells pretreated with macbecin at 37 °C (Fig. 5B). In
contrast, the weak interactions observed between HSP90 and α2B-AR
were not temperature-sensitive and not signiﬁcantly affected by
macbecin (Fig. 5A and B).
HSP90 chaperone class comprises from cytosolic (HSP90α and β),
endoplasmic reticulum (GRP94) and mitochondrial (TRAP-1) isoforms
[36–38]. The mitochondrial isoform is not involved in the regulation of
protein trafﬁcking from the endoplasmic reticulum to the plasma
membrane, but to distinguish between the other isoforms, the
endoplasmic reticulum isoform GRP94 was overexpressed in HEK293T
cells. No differences in the effects of low-temperature on the α2C-AR
plasma membrane levels were found between control and GRP94
overexpressing cells (Fig. 6A), supporting that the cytosolic HSP90
isoforms are modulating receptor trafﬁc. These cytosolic isoforms were
proposed to downregulate the cellular levels of some of its client
proteins through proteasomal degradation. However, this appears to be
not the case for α2C-AR, because in HEK293T cells two speciﬁc
proteasomal inhibitors, MG132 and lactacystin, failed to modify the
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(Fig. 6B).
3.4. The effects of low-temperature and HSP90 inhibition on the α2C-AR
functional responses
To test if low-temperature and HSP90 are also modulating the
functional responses to α2C-AR stimulation, the cAMP levels were
determined in HEK293T cells. The α2-AR agonist UK14304 (10−8 M)
itself had no effect on the basal cAMP levels in HEK293T cells at 37 °Cor at 30 °C (data not shown). Also, at 37 °C, UK14304 had minimal
effects on the forskolin-stimulated increase in cAMP levels (Fig. 7A).
Exposure to low-temperature up to 18 h at 30 °C did not change the
ability of forskolin to enhance the cAMP levels (Fig. 7A). However,
inhibition of cAMP formation by UK14304 was enhanced by exposure
to low-temperature in time-dependent manner (Fig. 7A), with
maximal effects after 18 h, similar to the effects observed on the
plasma membrane receptor levels (Fig. 1C). Further, pre-treatment
with the HSP90 inhibitors macbecin signiﬁcantly enhanced the effects
of receptor stimulation on this parameter (Fig. 7B). Noteworthy, the
UK14304 effects at 37 °C in presence of macbecin were not
statistically different from the effects of the agonist alone at 30 °C.
Lastly, at 30 °C macbecin did not change the effects of α2C-AR
stimulation on the cAMP levels, demonstrating that the inhibitors of
HSP90 are increasing the receptor activity only at 37 °C (Fig. 7B).
Cold-induced α2C-AR translocation to the plasma membrane has
been proposed to play a role in Raynaud Phenomenon. Therefore, this
study was extended to a more appropriate model for this disease,
namely contraction of the rat tail artery. In this preparation, rauwolscine
(1 μM), an α2-AR inhibitor, reduced the contractile effects of UK14304
withmore than80% (n=4, data not shown). The remaining effect could
be possibly attributed to activation ofα1-AR [12], but these effects were
previously shown to be temperature-independent [12,14]. Bothα2A-AR
andα2C-AR subtypes are expressed in this tissue [14], and for this reason
these experiments were conducted in presence of the α2A-AR inhibitor
BRL44408 and L-NAME to prevent the contribution of endothelial
vasoactive factors. Therefore, in these experimental conditions, the
contraction to UK14304 can be largely attributed to activation of
vascular α2C-AR. In agreement with the results in HEK293T cells, the
contractile effects in response to α2C-AR stimulation were enhanced
after one hour exposure at 30 °C (Fig. 8A and B). Again, pre-treatment
withmacbecin signiﬁcantly increased the contractile effects ofα2C-ARat
37 °C, but it was without effect at 30 °C (Fig. 8A and B). Importantly, the
log EC50 values of the UK14304 contractile effects were not statistically
different in these conditions (−6.76±0.13 and−6.537±0.06 at 37 °C,
vs.−6.90±0.11 and−6.753±0.19 at 30 °C, in absence or presence of
macbecin, respectively), indicating that macbecin is not affecting the
afﬁnity of the agonist for α2C-AR. Together, these results indicate that
low-temperature may reduce HSP90 activity and thus preventing
the inhibitory action on the receptor trafﬁcking. To test if this is the
case, theHSP90 levelswere determined inVSMC from rat tail artery. The
expression of α2C-ARwas conﬁrmed in these cells by western-blot. The
predicted molecular weight of the α2C-AR is 49.5 kDa, but we detected
multiple receptor species, with the major band around 65 kDa in bothFig. 4. The effects ofmanipulations in HSP90 activity on the temperature-dependentα2C-AR
plasma membrane expression. A. HEK293T cells were transfected with α2C-AR or with α2B-
AR(right columns, 3 μg/10 cm2plate left columns)and subsequentlyplatedon12-well plates
as described in Fig. 1. Six hours after FBSwaswithdrawn the cellswere incubated for 1 hwith
either vehicle (V), macbecin (M, 5 μM), 17-DMAG (17, 0.5 μM) or radicicol (R, 10 μM) and
subsequently exposed to 37 °C or to 30 °C for the next 18 h in the presence of the HSP90
inhibitors. The receptor plasmamembrane levelsweredetermined in intact cells as described
in Materials and methods. Mean±SD from 4 to 6 independent transfections. *indicate
pb0.05 compared to the vehicle. B. Dose-dependent effects of 17-DMAG on the wild-type
α2C-AR (triangles) andα2C322–325del-AR (squares) at 37 °C (black symbols) or at 30 °C (white
symbols). HEK293T were transfected as in A, and exposed to increased concentrations of
17-DMAG indicated on the x-axis;mean±SDwith n=4–8 for eachpoint from four different
transfections. C. Left panel demonstrate the reduction ofHSP90 expression levels inHEK293T
cells by siRNA targeting. HEK293T cells were ﬁrst transiently transfected withα2C-AR (3 μg/
10 cm2 plate). Six hours later the cells were trypsinized and replated on 12-well plates and
transfected with siRNA following the manufacturer instructions (Ambion). After 12 h the
mediumwas changed to DMEMwithout FBS and then processed as for radio-ligand binding
experiments. The result is representative from three independent transfections. Right panel:
quantitativedata expressedaspercentageof theHSP90 levels in control cells transfectedwith
control siRNA at 37 °C. mean±SD from three independent transfections. D. The effects of
HSP90 downregulation using siRNA on the α2C-AR plasma membrane levels at 37 °C and at
30 °C determined by [3H]RX821002 binding in intact cells in the same transfections as used
for the western blot experiments presented in C; mean±SD, n=9 from three independent
transfection. *indicate pb0.05 compared to the levels in control siRNA transfected cells at
37 °C.
Fig. 6. The effects of GRP94 overexpression and proteasomal inhibition on the α2C-AR
temperature-sensitive trafﬁcking. A. HEK293T cells were co-transfected with α2C-AR
and pcDNA 3.1 (left columns) or GRP94 (right columns). The cell surface α2C-AR levels
in cells maintained at 37 °C (black columns) or at 30 °C for 18 h (white columns) were
determined in intact cells as above. mean±SD, n=9 from three independent
transfections. B.α2C-AR transfected HEK293T cells were incubated with DMSO (vehicle,
0.1%), MG132 (10 μM) or lactacystin (5 μM) and subsequently exposed to 30 °C for 18 h
or maintained at 37 °C. The α2C-AR plasma membrane levels were determined in intact
cells. n=9 from three independent transfections.Fig. 5. Interactions betweenα2C-AR and HSP90 in HEK293T cells. A. HEK293T cells were
transfected with empty vector pcDNA 3.1, or HA-tagged α2C-AR and 3×HA tagged α2B-
AR (3 μg/10 cm2 plate each) and 6 h later the medium was changed to DMEM without
FBS, followed by incubation at 30 °C or at 37 °C for the subsequent 18 h. Some plates
were treated with macbecin (5 μM). Subsequently, the cells were solubilized and
immunoprecipitated with HA antibody as described under Materials and methods. The
HA immunoprecipitates (20 μg/lane) were separated by 10% SDS-Page and the HSP90
levels were revealed by Western-blotting. The experiment shown is representative
from three independent transfections. Similar results were obtained in case of α2C-AR
using GFP-tagged receptor and GFP antibody. B. Quantiﬁcation of the data presented in
A. mean±SD, n=3, *indicate statistical signiﬁcant differences compared with control
cells (pb0.05).
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[14,15], reﬂecting post-translationalmodiﬁcations of the receptor. From
these experiments it can be estimated that the endogenous receptor
levels in VSMC are about ~11 times less than in transfected HEK293T
cells.However, as expected from theﬂowcytometry results (Fig. 1H), no
differences were observed in total levels of the receptors in cells
maintained at 37 °C or exposed to 30 °C for 18 h in both cell types
(Fig. 9A). In contrast, exposure to 30 °C of VSMC from rat tail artery
signiﬁcantly reduced theHSP90 cellular levels (Fig. 9B andC). This effect
is speciﬁc for HSP90, as no changes in the levels of aα2C-AR,β-actin or of
HSP70 were found in these conditions (Fig. 9B and C).
4. Discussion
Within the GPCR class, α2C-AR has particular characteristics, being
poorly transported to the cell surface inﬁbroblasts and invascular smooth
muscle cells [8,9,12–15]. The present study was undertaken to clarify the
mechanisms controllingα2C-AR trafﬁcking in ﬁbroblasts and VSMC. Two
major ﬁndings resulted from these experiments, identiﬁcation of the
endoplasmic reticulum as the major site for the receptor intracellular
accumulation and the role of HSP90 in theα2C-AR trafﬁcking. Also, it has
been found that the effects of low-temperature are speciﬁc for this
receptor, because neither its closest homologue α2B-AR (Fig. 1D,F), norβ2-AR or β1-AR (Filipeanu, unpublished results) cell surface levels are
modiﬁed after exposure to low-temperature.
Previously, based on the effects of α2-AR antagonists, the receptor
localization in the peripheral vasculature, and speciﬁc upregulation of
the plasma membrane levels at reduced temperature, α2C-AR has been
proposed to play amajor role in the pathology of Raynaud Phenomenon
[12–15]. Although Raynaud Phenomenon is often perceived as a rare
disease, its world-wide incidence ranges from 4 to 20% of the general
population, the prevalence being higher in cold climates [10,11]. Even if
other factors like emotional stress and vibrations can precipitate the
symptoms, cold-exposure remains the major triggering factor for this
disease [10,11]. In the last decade many cellular biology studies
established that exposure to decreased temperatures (28–32 °C)
efﬁciently enhanced plasmamembrane targeting of misfolded proteins
[24,28]. The mechanisms involved in this effect appear to be similar to
the actions of the molecular chaperones [28]. The results from the
present work are in full agreement with this hypothesis, as the
stimulatory effects of DMSO and glycerol on the α2C-AR plasma
membrane levels were clearly visible at 37 °C, but absent in the cells
incubated at 30 °C (Fig. 2C). In addition, interfering with receptor
internalization did not change the effects of low-temperature on the
receptor trafﬁcking, indicating that α2C-AR poor plasma membrane
targeting is due to defects in the receptor export (Fig. 2A, B). This idea is
also supported by the co-localization experiments showing that the
endoplasmic reticulum is the major site for the receptor intracellular
accumulation at 37 °C (Fig. 3). Interestingly, the polymorphic variant
α2C322–325del-AR displayed similar increases in the cell surface levels at
low-temperature as α2C-AR wild-type (Fig. 1H), indicating that the
322GAGP325 fragment from the third intracellular is not essential for the
temperature-dependent trafﬁcking. The subcellularα2C-AR localization
ﬁndings from this study are in full agreement with earlier work from
Kobilka's group demonstrating that this receptor accumulates in the
Fig. 8. The effects of low-temperature and HSP90 inhibition on the contractile response
to α2C-AR stimulation in rat tail artery. A. Cumulative dose–effect contractile response
of rat tail artery to UK14304 in presence of L-NAME (100 μM) and α2A-AR antagonist
BRL44408 (1 μM). The responses obtained at 37 °C (black symbols) and after one hour
exposure to 30 °C (white symbols) in absence (squares) or after pretreatment with
10 μM macbecin (triangles) are expressed as percentage of the control contraction
induced by 100 mM KCl. mean±SD from four different preparations obtained from
four different animals. One-way ANOVA followed by Bonferroni's Multiple Comparison
Test revealed that the contractile effects at 37 °C in control arteries are signiﬁcantly
lower compared to the other three conditions. B. Same data as in A presented as
maximal contractile response to 100 μM UK14304 at 37 °C (left columns) and at 30 °C
(right columns) in absence (black columns) or presence of 10 μM macbecin (white
columns). *indicate statistical signiﬁcant differences with pb0.05.
Fig. 7. The effects of low-temperature and macbecin on α2C-AR mediated cAMP
inhibition in HEK293T cells. A. α2C-AR transfected HEK293T cells (3 μg/10 cm2 dish)
were plated in 24 well plates and serum-starved for 24 h. Subsequently, the cells were
incubated at 30 °C for the periods indicated under the graph. At the end of the
incubation period the medium was changed to PBS containing 100 μM IBMX for one
hour. Subsequently the cells were pretreated with UK14304 (10 nM) for 5 min,
followed by stimulation with forskolin (10 μM) for 15 min. The reactions were stopped
by medium aspiration and addition of 200 μl thhricloracetic acid and cAMP levels were
determined using cAMP Elisa Kit (Cayman Biochemicals) as described in Materials and
methods. B. Same as in A., but the cells were incubated at 37 °C or at 30 °C in absence or
presence of macbecin (5 μM) for 18 h. n=12–15 in each case from three independent
transfections. *shows statistical signiﬁcant differences between the effects of UK14304
at 37 °C and all other series with pb0.05.
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cell lines with ﬁbroblast phenotype [8,9]. However, other studies
reported a trans-Golgi localization of the receptor inα2C-AR transfected
HEK293T cells [14,15,39]. The reasons for this discrepancy are unclear,
but it could be related to the differences in the transfection procedure
and/or in the organelle markers used. Very recently, Angelotti et al. also
found that in physiological conditions α2C-AR is targeted to the
endoplasmic reticulum, possibly by a hydrophobic motif located in the
receptor N-terminus [40]. In addition, our study is ﬁrst to directly
quantify the amount of the receptor translocated from intracellular
organelles to the plasmamembrane at low-temperature by radioligand
binding. We found similar results using untagged and tagged α2C-AR
(Fig. 1G), indicating that this receptor has an intrinsic folding defect and
exposure to low-temperature facilitates the receptor stabilization and
allows its inclusion in the export trafﬁcking pathways.
Our data demonstrate for the ﬁrst time the role of HSP90 in the
α2C-AR intracellular trafﬁc regulation. The folding of the newly
synthesized proteins and the subcellular transport is assisted bymany
specialized proteins, broadly named molecular chaperones [16,17].
These molecular chaperones belong to different classes and intervene
at different steps during proteinmaturation or trafﬁcking, modulating
the transport rate and the subcellular localization [16–19]. In the caseof misfolded proteins it has been repeatedly demonstrated that
several molecular chaperones, actively prevent formation of aggre-
gates by triggering the unfolded protein response [17,25]. In
particular, HSP90 has been shown tomodulate the folding, stabilization,
activation, and assembly of a wide range of proteins [36–38]. Still, in
contrast with other molecular chaperones, HSP90 has a distinct
repertoire of speciﬁc ‘client’ proteins with which it interacts, playing
the role of scaffold and regulating thematuration and signaling of these
molecules [36–38]. Alterations in the HSP90 activity have been
demonstrated to modify the intracellular trafﬁcking and plasma
membrane targeting of different mutants of CFTR, insulin receptor and
nicotinic receptor [21–23]. Thus far, just one another GPCRmember, the
cannabinoid CB2 receptor has been reported to interact with HSP90 and
this interaction is required for the receptor mediated cell migration
through the Gαi–Rac1 pathway [41]. However, no attempt to quantify
the HSP90 effects on the receptor subcellular localization and plasma
membrane expression was performed in the respective study.
The inhibitory role of HSP90 on the α2C-AR trafﬁc to the plasma
membrane was demonstrated in the present study by two separate
and complimentary means, inhibition of its activity using speciﬁc
Fig. 9. The inﬂuence of temperature on the HSP90 and HSP70 levels in the vascular
smooth muscle cells from rat tail artery. A. α2C-AR levels in VSMC from rat tail artery
and HEK293T cells. 20 μg of cell lysates obtained from VSMC from rat tail artery (P2, left
lanes) and α2C-AR transfected HEK293T (right lanes) maintained for 18 h at 37 °C or at
30 °C were separated by 10% SDS PAGE. The α2C-AR levels were determined by western
blotting using a speciﬁc antibody. Similar results were obtained in three other
experiments. B. HSP90 and HSP70 levels in VSMC from rat tail artery. VSMC from rat tail
artery (P2) were serum starved for 48 h and subsequently maintained at 37 °C or
exposed to 30 °C for 18 h. The cell lysates (20 μg/lane) were separated by 10% SDS-Page
and subject to western-blotting with speciﬁc antibodies. A representative blot out of
three independent cell isolations is shown. C. The levels of HSP90 (black column) and
HSP70 (white column) at 30 °C in VSMC from rat tail artery quantiﬁed from the
experiments shown in B. Data are expressed as % of the levels of each HSP at 37 °C.
mean±SD, from three independent experiments. *indicate statistical signiﬁcant
differences with pb0.05.
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(Fig. 4). Similar results were obtained with both approaches,
demonstrating that HSP90 activity is essential for the receptor
accumulation at the physiological temperature. Again, wild-type α2C-
AR and α2C322–325del-AR polymorphic variant have similar sensitivity
(Fig. 4B), clearly showing that both isoforms have similar trafﬁcking
properties at least in respect to the effects of low-temperature and
HSP90 modulation. Because no changes were observed in the total
receptor levels at the two temperatures (Figs. 1E and 9A), and the
speciﬁc proteasomal inhibitors MG132 and lactacystin have no effects
on the α2C-AR trafﬁcking (Fig. 6B), it can be concluded that low-
temperature acts by releasing the inhibitory mechanisms preventing
the receptor transport at physiological temperature. Based on the
absence of HSP90 inhibitors at 30 °C, it can be assumed that these
mechanisms are at least in part mediated by HSP90.
HSP90 hasmultiple isoformswith different subcellular localization
and different functions [36–38]. The current HSP90 inhibitors are a
little more effective against the cytosolic isoforms [42]. Indeed,
overexpression of GRP94, the endoplasmic reticulum HSP90 isoform,had no effect on the α2C-AR trafﬁcking. This ﬁnding is not surprising,
considering that in contrast to other endoplasmic reticulum resident
molecular chaperones, GRP94 has been suggested to have a limited
number of interacting partners [43]. The correlation between the data
obtained with three distinct HSP90 inhibitors and speciﬁc down-
regulation of cytosolic HSP90 levels using siRNA, demonstrate that
only these isoforms are modulating α2C-AR temperature-dependent
trafﬁcking. The two HSP90 cytosolic isoforms are designed α and β
and are closely related (86% identitity and 93% similarity), with the
most important sequence difference in the N-terminus. [37]. Although
both isoforms are present under basal conditions, HSP90α usually
shows a larger increase after heat shock and therefore is credited to be
the inducible isoform, whereas HSP90β which has lesser variations is
considered the constitutive isoform [36–38]. However, each isoform
may substitute the other in the cellular functions. Also, the
experimental tools to differentiate between the HSP90 isoforms are
limited, as the two cytosolic isoforms have similar sensitivity to HSP90
inhibitors, share the same co-chaperones, form heterodimers and the
antibodies cross-react. Based on these reasons, no attempt was made
in the present study to differentiate which isoform is crucial for the
temperature-sensitive α2C-AR trafﬁcking.
The enhanced α2C-AR plasma membrane expression at low-
temperature and/or after HSP90 inhibition is reﬂected by increased
functional responses after receptor stimulation in these conditions.
The classical physiological view attributes all the GPCR function to the
receptors present at the cell surface, freely accessible to the
extracellular ligands. However, this paradigm was challenged in the
last decade, activation of cellular signaling by receptors with
intracellular localization being demonstrated in several situations
[44–46]. However, the large pool of α2C-AR localized in the
endoplasmic reticulum at physiological temperature appears unable
to contribute to cellular responses. In fact, the effects on cAMP and
vascular tone observed at 37 °C are exclusively due to activation of the
receptor fraction with plasma membrane localization, as they are
eliminated by addition of the extracellular α2-AR antagonist,
rauwolscine (data not shown). The inability of intracellular α2C-AR
to trigger cellular signalingmay be related to the absence of molecules
required to trigger signaling (i.e. G protein subunits) at this level.
However, recent data indicate that GPCR are associated in signaling
complexes with the correspondingmolecules early in the biosynthetic
pathway [47]. More probably, appropriate receptor activators are
unable to reach the intracellular α2C-AR. Still, our results cannot
exclude the possibility that intracellular α2C-AR activates other
unknown yet signaling mechanisms. In contrast, when the receptor
expression at the cell surface is increased by low-temperature and/or
HSP90 inhibition, the modulation of cAMP levels and contractile
effects in response to the α2-agonist are markedly enhanced. The
similarity of the effects of low-temperature and HSP90 inhibition on
α2C-AR functional responses in HEK293T cells and rat tail artery
demonstrate that the temperature-sensitive receptor trafﬁcking is not
limited to heterologous transfection systems. The effects of low-
temperature on α2C-AR plasma membrane expression were absent
only in PC12, a neuro-endocrine cell line, in agreement with previous
ﬁndings [9]. Different expression of HSP90 isoforms (or speciﬁc co-
chaperones) in neurons and in smoothmuscle cells have been reported
[48] and this fact may explain the cell-speciﬁc receptor trafﬁcking.
The current study reveals a novel aspect of HSP90 inhibitors,
speciﬁcally modulation of vascular tone. Previously, impairment of
the endothelium-dependent relaxation by these agents was observed
in the porcine coronary arteries and rat thoracic aorta [49,50], but a
direct effect on vascular smooth muscle, as in the present study, has
not been reported. Various HSP90 inhibitors are currently in clinical
trials for treatment of different types of cancer [51,52]. When the data
and ﬁndings from these trials is reported, it will be interesting to
determine if there is an association between the use of HSP90
inhibitors and clinical manifestations of Raynaud Phenomenon and it
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to identify individuals susceptible to this disease.
In correlation with the ﬁndings on the receptor cell surface levels,
the effects of low-temperature and HSP90 inhibitors on the α2C-AR
functional effects in HEK293T cells and rat tail artery were not
additive, indicating that a common mechanism may underlie these
effects. This conclusion is supported by the co-immunoprecipitation
experiments which demonstrated strong interaction between these
two proteins at 37 °C (Fig. 5A). Based on these data, α2C-AR should be
added to the growing list of HSP90-interacting proteins. The
interactions between α2C-AR and HSP90 were decreased at 30 °C,
supporting the idea that low-temperature may release the inhibitory
action of HSP90 on the receptor trafﬁc. This temperature-dependent
interaction was speciﬁc for α2C-AR, as it was not observed in the case
of α2B-AR (Fig. 5). HEK293T cells express large amounts of
endogenous HSP90 compared to VSMC from rat tail artery (Supple-
mentary Fig. 2), and this fact may explain the long time interval
required to observe the maximal effect of low-temperature on the
α2C-AR plasma membrane levels (~18 h, Fig. 1A), which is in contrast
with rapid onset of the Raynaud Phenomenon [10,11]. Endogenous
HSP90 levels are well known to be higher in cancer or immortalized
cell lines compared to normal cells [51,52]. Thus, the high endogenous
HSP90 levels in HEK293T may mask the contribution of other
mechanisms like Rho kinase, Rap GTP-ase and JNK [14,15,39,53,54]
to the temperature-dependent α2C-AR intracellular trafﬁcking. How-
ever, a clear and speciﬁc reduction of about 50% in HSP90 levels was
found in VSMC from rat tail arterymaintained at 30 °C for 18 h (Fig. 9).
Although mild heat shock is the hallmark of heat shock protein
upregulation, currently little is known about to the effects of low-
temperature on the HSP levels. Recently it has been proposed that
cold-exposure may destabilize HSP90 in cell free environment leading
to its rapid degradation [55]. Still, considering that the largest effect at
30 °C on the α2C-AR trafﬁcking was observed in HEK293T cells,
additional mechanisms may regulate the interactions between α2C-AR
and HSP90 at low temperature, including translocation of HSP90 into
cellular compartments in which is not able to bind to receptor.
Interestingly, stimulation of estrogen receptors through activation of
Rap GTP-ase have been also proposed to modulate the effects of low-
temperature on theα2C-AR [53,54]. On the other hand, HSP90 inhibition
has beenshown toblock thenon-genomic estrogen signaling [49] and to
prevent GPCR activation of small GTP-ases [41]. Thus, HSP90 may
integrate different subcellular mechanisms to regulate temperature-
sensitive α2C-AR trafﬁcking.
In conclusion, two new important features of α2C-AR intracellular
trafﬁcking were characterized in the present investigation, identiﬁcation
of theendoplasmic reticulumas themajor siteof the receptor intracellular
accumulation at 37 °C and demonstration that low-temperature acts by
weakening the α2C-AR interactions with cytosolic HSP90 to promote the
receptor transport to the cell surface.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2010.11.020.
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